Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
100 , 346S349S (1993)
Meanwhile, tirzepatide has not increased the risk of MACE in type 2 diabetes patients (SURPASS-4) 4 and has been shown to lower the 10-year predicted risk of atherosclerotic cardiovascular disease (ASCVD) in overweight and obese adults 5
JAMA Neurol 2025
If five companies have TAs in hand for a drug with a 2028 LOE date, the first day of competition is likely to be intensely competitive, with rapid price erosion driven by five players simultaneously seeking formulary access
We defined the ideal number of parasites needed to achieve a rate of infection that was reliably detectable by our high-content imaging platform, with room for the infection rate to significantly decrease or increase and still be detectable, while also not causing too much host cell death
